Middle East and Africa Neurovascular Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product ; Application ; End User and Country
Market Introduction Neurovascular devices are used to treat neurovascular diseases that possibly affect the network of blood vessels that surround the brain.Neurovascular disorders lead to incurable conditions such as strokes and aneurysms.
Neurovascular devices are used to prevent stroke, aneurysm embolization, carotid stenosis, and other symptoms. Neurovascular devices are also used for performing surgical procedures to treat aneurysms and other cranial blood flow problems.
Market Overview and Dynamics The Middle East and Africa neurovascular devices market is expected to reach US$ 144.08 Mn in 2027 from US$ 119.85 Mn in 2019. The market is estimated to grow with a CAGR of 2.4% from 2020-2027. Key factors that are driving growth of Middle East and Africa Neurovascular Devices market are Increasing Incidences of neurovascular diseases, rising demand for minimally invasive procedures, and significantly growing aging population. However, the market is expected to grow at slower pace owing to the factors such as high cost of embolization coils and lack of expert professionals operating neurovascular disorders.
Key Market Segments The Middle East and Africa neurovascular devices market, based on the product was segmented into neurothrombectomy devices, aneurysm coiling & embolization devices, cerebral balloon angioplasty & stenting systems and support devices. The aneurysm coiling & embolization devices held the largest share of the market in 2019, and is anticipated to register the highest CAGR in the market during the forecast period. The Middle East and Africa neurovascular devices market, based on the application was segmented into cerebral aneurysms, ischemic strokes, arteriovenous malformation & fistulas, and other applications. In 2019, ischemic strokes segment held the largest share of the market and is expected to register the highest CAGR in the market during the forecast period. Based on end user, the Middle East and Africa neurovascular devices market, was segmented into hospitals, ambulatory surgical centers and specialized clinics. In 2019, hospitals segment held the largest share of the market and is registered to dominate the market at the highest CAGR during the forecast period.
Major Sources and Companies Listed Some of the major primary and secondary sources for Middle East and Africa neurovascular devices market included in the report are Neurology Association of South Africa (NASA); World Bank; World Stroke Organisation (WSO); and World Health Organisation (WHO); among others.
Middle East and Africa North America Neurovascular Devices market – By Product • Neurothrombectomy Devices o Clot Retrieval Devices o Suction & Aspiration Devices o Snares • Aneurysm Coiling & Embolization Devices o Embolic Coils Bare Detachable Coils Coated Detachable Coils o Flow Diversion Devices o Liquid Embolic Agents • Cerebral Balloon Angioplasty & Stenting Systems o Carotid Artery Stents o Embolic Protection Systems Balloon Occlusion Devices Distal Fillers • Support Devices o Microcatheters o Microguidewires By Application • Cerebral Aneurysms • Arteriovenous Malformation & Fistulas • Other Applications By End User • Hospitals • Ambulatory Surgical Centers • Specialized Clinics By Country o UAE o Saudi Arabia o South Africa o Rest of Middle East and Africa
Company Profiles
• Medtronic plc • Johnson and Johnson, Inc (DePuy Synthes) • Penumbra, Inc • Terumo Corporation • Acandis GmbH & Co. KG
Our reports have been used by over 10K customers, including:
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global IV and Oral Iron Drugs Market Report
The global IV and oral iron drugs market by revenue is expected to grow at a CAGR of 11.6% during the period 2021–2026.
The global IV and oral iron drugs market is expected to grow due to the prevalence...
242 pages •
By The Business Research Company
• Dec 2020
CAR-T Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global CAR-T Therapy market. Description: Where is the largest and fastest growing market for the CAR-T therapy...
The biofilms treatment market was valued at US$ 1,590.31 million in 2019 and is projected to reach US$ 2,825.80 million by 2027; it is expected to grow at a CAGR of 7.5% during 2020–2027. The increasing incidence of wounds and ulcers, and growing number of surgical procedures across the world fuel the market growth. Moreover, continuous innovations...
The global cancer cachexia market was valued at USD 2,256.35 million in 2020, and it is expected to reach USD 2,974.49 million by 2026, registering a CAGR of 4.47% during the forecast period. The outbreak of COVID-19 impacted the cancer cachexia market, as hospitals and healthcare services were significantly reduced due to social distancing...
The South & Central America closed systems drug transfer devices market is expected to reach US$ 118.49 million by 2027 from US$ 28.37 million in 2019; it is estimated to grow at a CAGR of 19.6% from 2020 to 2027. The closed systems drug transfer devices market in South & Central America is primarily driven by rise in adoption of chemotherapy...
181 pages •
By The Business Research Company
• Dec 2020
Human Microbiome Therapeutics Global Market Opportunities And Strategies To 2030: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global human microbiome therapeutics market. Description: Where is the largest and fastest growing...
The Middle East and Africa addictions therapeutics market is expected to reach US$ 223.05 million by 2027 from US$ 172.05 million in 2019. The market is estimated to grow with a CAGR of 3.4% from 2020-2027. The growth of the market is attributed to the rising approval of new drugs and launch of digital therapeutics to treat addiction, and...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
The market is expected to reach US$ 11,614.32 million in 2027 from US$ 9,106.40 million in 2019. The market is estimated to grow with a CAGR of 3.2% from 2020-2027. The growth of the market is attributed to some key driving factors such as growing prevalence of urinary tract infections, aging population and emerging computing technologies...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Drug-Coated Balloons Market Report
The drug-coated balloons market by revenue is expected to grow at a CAGR of 15% during the period 2019–2025.
The global drug-coated balloons market is one of the fastest-growing segments in the cardiovascular...
Hospital
Therapy
Clinical Trial
Cardiovascular Devices
Anti-Infective
World
Elderly Population
Drug Approval
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.